NMDA/glycine modulators (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameNMDA/glycine modulators (AstraZeneca)

Drug Alias Namedual NMDA/glycine-modulating analgesics (AstraZeneca)pyridazinoquinolones (AstraZeneca)analgesic pyridazinoquinolines (AstraZeneca)AZ-756AZ-969

ClassificationSmall molecules

Mechanisms of ActionGlutamate [NMDA] receptor modulators

TargetsGlutamate [NMDA] receptor

Therapy Area/IndicationsPain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsPain

Other Information

ATC CodeN/A